PolatNOylumluMIşikMA, et al.Prognostic significance of serum albumin in patients with acute coronary syndrome. Angiology. 2020;71:903–908. doi:10.1177/0003319720941747
2.
ÇınarTÇağdaşMRencüzoğullarıİ, et al.Prognostic efficacy of C-reactive protein/albumin ratio in ST elevation myocardial infarction. Scand Cardiovasc J. 2019;53:83–90.
3.
ChienSCChenCYLinCFYehHI. Critical appraisal of the role of serum albumin in cardiovascular disease. Biomark Res. 2017;5:31.
4.
TanıkVOÇınarTKarabağY, et al.The prognostic value of the serum albumin level for long-term prognosis in patients with acute pulmonary embolism. Clin Respir J. 2020;14:578–85.
5.
NeumannFJSousa-UvaMAhlssonA, et al.2018 ESC/EACTS Guidelines on myocardial revascularization. EuroIntervention. 2019;14:1435–534.
6.
AmsterdamEAWengerNKBrindisRG, et al.2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014;64:e139–e228.
7.
ChenYHHuangSSLinSJ. TIMI and GRACE risk scores predict both short-term and long-term outcomes in Chinese patients with acute myocardial infarction. Acta Cardiol Sin. 2018;34:4–12.
8.
AkyuzSYaziciSBozbeyogluE, et al.Validity of the updated GRACE risk predictor (version 2.0) in patients with non-ST-elevation acute coronary syndrome. Rev Port Cardiol. 2016;35:25–31.
